Close Menu

aneuploidy

The data demonstrate that the performance of NIPT demonstrated in earlier smaller studies has held true in the context of a dramatically expanded group of clinical samples.

The revenue projection falls short of analyst estimates of $45 million for the quarter and $161 million for the year. 

The companies reached an exclusive deal to provide Natera's Panorama NIPT in the Indian market. 

The company's goal is to transition from a one-test provider to a full-service genetic testing company in the reproductive health and potentially other markets.

The FAST-SeqS test screens embryos for chromosomal aneuploidies prior to implantation in an in vitro fertilization setting. 

Under the agreement, VCGS will develop its own non-invasive prenatal test using Illumina's sequencing technology.

The decision invalidates 13 claims of a patent that is at the center of litigation filed by Illumina alleging infringement by Ariosa Diagnostics.

NEW YORK (GenomeWeb) – Microarray-based non-invasive prenatal testing firm CellScape has shut down.
According to its LinkedIn page, the company, which had been headquartered in Newark, Calif., ceased operations in September.

NEW YORK (GenomeWeb) – Sequenom is looking to its deal with Quest Diagnostics and a new noninvasive prenatal test, VisibiliT, which it will launch in Europe for trisomies 21 and 18, to help drive new revenue growth, company officials said this week.

NEW YORK (GenomeWeb) — Affymetrix and Ariosa Diagnostics today announced that they have signed a multi-year agreement under which Affymetrix will supply arrays and instruments for use in Ariosa's Harmony non-invasive prenatal test.

Pages

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.